Immunotherapy and Transarterial therapy of HCC: What the interventional radiologist needs to know about the changing landscape of HCC treatment?

Hepatocellular carcinoma (HCC) is the fourth most common cancer worldwide and its incidence is increasing in Australia. Transarterial therapy, predominantly transarterial chemoembolization (TACE) but increasingly transarterial radioembolization (TARE), plays an important role in patients with interm...

Descripción completa

Detalles Bibliográficos
Autores principales: Tibballs, Jonathan, Clements, Warren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
MEDICAL IMAGING
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311219/
https://www.ncbi.nlm.nih.gov/pubmed/35357076
http://dx.doi.org/10.1111/1754-9485.13405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311219/
https://www.ncbi.nlm.nih.gov/pubmed/35357076
http://dx.doi.org/10.1111/1754-9485.13405

Ejemplares similares